āagman

Not investment advice. Data and computed figures, for information only.

Sanofi Consumer Healthcare India Ltd

NSE: SANOFICONR
₹3,548.70
−₹24.60 (−0.69%)
NSE · 16 Oct 2026, close
NSE
As of 31 Dec 2025
Market Cap
₹9,086 Cr
CMP
₹3,548.70
52-wk High / Low
₹5,255 / 3,530
P/E
34.2
P/B
26.1
Book Value
₹151.0
Div Yield
1.90%
ROCE
90.0%
ROE
71.6%
Face Value
₹10
D/E
0.07

Price−23.2% over 1Y

āagman read

Computed by āagman
Derived from 4 years and 12 quarters of filings. Not reported by the company.
As of 16 Oct 2026
How we compute these
Piotroski F-Score
2
/ 9
2 of 9 F-score tests passed
Graham Number
₹595
√(22.5 × EPS × book value per share)
ROIC
54.5%
vs 11.2% sector median
Cash flow to profit
0.73
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+604
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
25.1%
ROE × earnings retention ratio
ROE stability
7.2
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII −0.16DII +0.28
Latest quarter vs the previous one
Cash-accrual divergence
11.9%
of assets
Low = accruals track cash flow
Strengths
+PE of 34.2x is below the sector median of 45.9x
Watch-outs
−Price trades below its 200-day moving average (0.8x)
−Price is 32.5% below its 52-week high
−Piotroski F-Score of 2/9 is in the weak band (≤3)
−Balance-sheet accruals of 11.9% of average assets — earnings are not cash-backed

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Standalone basis (as filed) · ₹ Cr · 12 quarters
As of 30 Jun 2026
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales210225222172160171173221234251229236
Expenses11613514010997109109151149161140146
Operating Profit959082646362647085908989
OPM %45.2%40.0%36.9%37.2%39.4%36.3%37.0%31.7%36.3%35.9%38.9%37.7%
Other Income113−24325123566
Interest000030001000
Depreciation111121233333
Profit before tax959084396163677984909192
Net Profit716863294544506163666869
EPS (₹)———12.5919.5419.2421.7126.3627.3128.8729.4429.87

Profit & Loss

As of 30 Jun 2026
Standalone · ₹ Cr · 5 years + TTM
Dec 2023Dec 2024Mar 2025Dec 2025Jun 2026TTM
Sales555724878878—950
Expenses337454569569—597
Operating Profit219271309309—353
OPM %39.5%37.4%35.2%35.2%—37.2%
Other Income2−152525—20
Interest0422—2
Depreciation241212—13
Profit before tax219247320320—357
Net Profit165181240240—266
EPS (₹)—78.59104.25104.25—115.49

Balance Sheet

As of 30 Jun 2026
Standalone · ₹ Cr
Dec 2023Dec 2024Mar 2025Dec 2025Jun 2026Jun 2026
Equity Capital223—2323—
Reserves206250—361325—
Borrowings020—2521—
Other Liabilities138138—138338—
Total Liabilities345431—547706—
Fixed Assets529—3630—
CWIP31—00—
Investments00—00—
Other Assets338402—511677—
Total Assets345431—547706—

Cash Flows

As of 31 Dec 2025
Standalone · ₹ Cr
Dec 2023Dec 2024Mar 2025Dec 2025
Cash from Operating Activity0439—175
Cash from Investing Activity02—8
Cash from Financing Activity2−116—−134
Net Cash Flow2325—48

Ratios

As of 31 Dec 2025
4 periods
Dec 2023Dec 2024Mar 2025Dec 2025
ROCE %—111.0—90.0
ROE %———71.6
EPS (₹)—78.59104.25104.25
Book Value (₹)———151.0
Face Value (₹)———10
P/E———34.2
Div Yield %———1.90
NPM %29.625.526.626.6
OPM %39.037.035.035.0
D/E0.000.07—0.07
P/B———26.1

Growth

As of 27 Sep 2026
Compounded sales growth
TTM+31.0%
Compounded profit growth
TTM+34.0%
Stock price CAGR
Last year−20.0%
Return on equity
3 years78.0%
Last year72.0%

Shareholding pattern

As of 31 Dec 2024
Jun 2024Sep 2024Dec 2024
Promoters60.40%71.27%71.27%
FIIs4.52%2.76%2.60%
DIIs25.48%17.57%17.85%
Government———
Public9.59%8.41%8.28%
No. of shareholders51,85948,41847,511
Change since Jun 2024 (pp)
Promoters +10.87FIIs −1.92DIIs −7.63Public −1.31

Documents

As of 27 Sep 2026
Announcements
Announcement under Regulation 30 (LODR)-Newspaper PublicationAnnouncement under Regulation 30 (LODR)-Press Release / Media ReleaseResults - Financial Results For June 30, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, 28Th July 2026Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026.
Annual reports
Annual Report 2025Annual Report 2024Annual Report 2024
Concalls
Mar 2026TranscriptMar 2026PPT

Corporate actions

As of 19 Jun 2026
19 Jun 2026DIVIDENDDividend - Rs 75 Per Share—
17 Apr 2025DIVIDENDDividend - Rs 55 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman